BioSpace News Archive

Cybrexa Therapeutics announced that it has expanded its Scientific Advisory Board with the appointment of Roy S. Herbst, M.D., Ph.D., Ensign Professor of Medicine, Professor of Pharmacology, Chief of Medical Oncology, Director of the Yale SPORE in Lung Cancer, and Associate Director for Translational Research at Yale Cancer Center and Yale School of Medicine.

Nabriva Therapeutics plc, a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, announced that it will report its second quarter financial results after the close of the U.S. financial markets on Thursday, August 6, 2020.

Antares Pharma, Inc., a pharmaceutical technology company, announced they have entered into an exclusive distribution agreement with Lunatus Global Medical Supplies to distribute and promote the sale of XYOSTED® in Saudi Arabia and the United Arab Emirates.

LHC Group, Inc. announced that it has finalized a new joint venture agreement with Orlando Health System in Orlando, Fla., effective August 1.

Microbot Medical Inc. has further strengthened the Company’s capabilities and expertise as Mr. Tal Wenderow, an experienced medical device and robotics executive with a proven track record in small and mid-size companies, has been appointed to the Company’s Board of Directors.

Temasek Life Sciences Accelerator-backed PATHNOVA to Offer COVID-19 Testing Kits Supplied by Todos in Singapore and Southeast Asia

GW Pharmaceuticals plc along with its U.S. subsidiary Greenwich Biosciences, Inc., announced the U.S. Food and Drug Administration has approved EPIDIOLEX® oral solution to treat seizures associated with tuberous sclerosis complex in patients one year of age and older.

INmune Bio, Inc., a clinical-stage immunology company focused on developing treatments that harness a patient’s innate immune system to fight disease, announced that management will be presenting a corporate overview at the BTIG Virtual Biotechnology Conference being held August 10-11, 2020 and will also be available for 1x1 meetings.

Bio-Techne Corporation and the Mount Sinai Health System in New York, through its commercial affiliate Kantaro Biosciences LLC, announced the anticipated launch of the COVID-SeroIndex, a Kantaro Quantitative SARS-CoV-2 IgG Antibody RUO kit.

Kadimastem Ltd., announced that its lead product, AstroRx®, showed a positive efficacy signal and a good safety profile in Cohort B of the Company’s Phase 1/2a clinical trial in ALS.